Lumbar Interbody Fusion with Autograft ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
70Spinal stenosis1

70. Spinal stenosis


Clinical trials : 96 Drugs : 203 - (DrugBank : 60) / Drug target genes : 66 - Drug target pathways : 89
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00996073
(ClinicalTrials.gov)
September 20099/10/2009Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody FusionA Prospective, Multicenter, Randomized, Open-Label, Controlled Study Evaluating Safety and Preliminary Efficacy of NeoFuse When Combined With MasterGraft Matrix in Subjects Undergoing Lumbar Interbody Fusion With InstrumentationDegenerative Disc Disease;Degenerative Spondylolisthesis;Spinal StenosisBiological: Lumbar Interbody Fusion with Autograft;Biological: Lumbar Interbody Fusion with NeoFuseMesoblast, Ltd.NULLCompleted18 Years70 YearsAll24Phase 2United States